NEEDS REVIEW
As of September 22, 2026 at 1:27 AM, this is how Optics News reads the wording differences in this story.
What happened Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
The headline split The headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidence Developing. Only 6 sources are matched, and the source map is still narrow. Useful to watch, not enough to draw conclusions yet.
Same-event confidenceDevelopingNot enough sources yet to confirm this is the same specific event.
Framing confidenceHiddenWording-gap score not shown — same-event match is still developing.
Wording differs, but the match is too narrow to read confidently yet.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.Optics keeps watching for pickup.
CenterWegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAIONKABC / ABC7 Los Angeles · Center · News report
Right / center-rightNo matching source in this bucket yet.Optics keeps watching for pickup.
SEE THE HEADLINES
Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.
DetailsScore hidden · 6 sources · 1 bias buckets
Score hidden until the match is cleanerLow confidence6 sources · 1 bias bucketsDeveloping · 6 sources · 1 bucketFormats: News report
SOURCE MAP CHANGES
Sep 22, 1:27 AM: KABC / ABC7 Los Angeles joined the source map.
Sep 22, 1:27 AM: WLS / ABC7 Chicago joined the source map.
Sep 22, 1:27 AM: KGO / ABC7 San Francisco joined the source map.
Sep 22, 1:27 AM: WPVI / 6abc Philadelphia joined the source map.
Now: score hidden until the source match is cleaner. Story health is developing · 6 sources · 1 bucket.